Publication

Early versus Later Anticoagulation for Stroke with Atrial Fibrillation.

Journal Paper/Review - May 24, 2023

Units
PubMed
Doi
Contact

Citation
Fischer U, Koga M, Strbian D, Branca M, Abend S, Trelle S, Paciaroni M, Thomalla G, Michel P, Nedeltchev K, Bonati L, Ntaios G, Gattringer T, Sandset E, Kelly P, Lemmens R, Sylaja P, Maurice De Sousa D, Bornstein N, Gdovinova Z, Yoshimoto T, Tiainen M, Thomas H, Krishnan M, Shim G, Gumbinger C, Vehoff J, Zhang L, Matsuzono K, Kristoffersen E, Desfontaines P, Vanacker P, Alonso A, Yakushiji Y, Kulyk C, Hemelsoet D, Poli S, Paiva Nunes A, Caracciolo N, Slade P, Demeestere J, Salerno A, Kneihsl M, Kahles T, Giudici D, Tanaka K, Räty S, Hidalgo R, Werring D, Goeldlin M, Arnold M, Ferrari C, Beyeler S, Fung C, Weder B, Tatlisumak T, Fenzl S, Rezny-Kasprzak B, Hakim A, Salanti G, Bassetti C, Gralla J, Seiffge D, Horvath T, Dawson J, Kägi G. Early versus Later Anticoagulation for Stroke with Atrial Fibrillation. N Engl J Med 2023; 388:2411-2421.
Type
Journal Paper/Review (English)
Journal
N Engl J Med 2023; 388
Publication Date
May 24, 2023
Issn Electronic
1533-4406
Pages
2411-2421
Brief description/objective

The effect of early as compared with later initiation of direct oral anticoagulants (DOACs) in persons with atrial fibrillation who have had an acute ischemic stroke is unclear.